ABSTRACT. Tetrahydrocannabinol (THC), the active component in marijuana smoke, crosses the placenta and is a potential fetotoxic agent. In both human and animal studies, the most consistent fetal effect of THC is intrauterine growth retardation. Since fetal somatic growth is dependent on placental transfer of nutrients, including essential amino acids, we studied the effect of THC upon the in vitro uptake of amino acid by term human placental slices. Uptake of a-amino isobutyric acid was inhibited in a dose-dependent fashion, correlating with the log of the dose (1-100 pM THC; r = 0.945; p < 0.01). Compared to control tissue, significant impairment of 0-amino isobutyric acid uptake began at 20 pM THC. Similar results were found for valine. The time course (30-120 min) for a-amino isobutyric acid uptake showed linearity for both control and THC-(50 pM) treated tissue, but there was a marked reduction in the THC slope. Uptake of a-amino isobutyric acid was significantly reduced at all times. The sustained effect of THC was slightly, but significantly, reversed by removal of THC from the medium after 90 min of 50 pM THC exposure. Only partial reversal may have been due to the 15-to 20-fold accumulation of THC in the placental tissue. Uptake kinetics showed noncompetitive inhibition with decreased Vmax: control Vmax = 51.66 f 6.26 versus 50 pM THC = 26.96 f 6.22 (mmol/ liter intracellular water per h) ( p < 0.01); and no change in diffusion constant (Km): control Km = 0.78 f 0.08 versus 50 pM THC = 0.80 2 0.09 (mM). In addition, 50 pM THC caused a modest increase in Kd, but the difference was not significant: control Kd = 3.82 f 0.29 versus 50 pM THC = 5.19
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Marijuana is a commony used illicit drug. The major active component in marijuana smoke, THC, crosses the placenta (1, 2). Under in vitro conditions, THC can be cytotoxic (3, 4) . Therefore, marijuana exposure during pregnancy carries the potential for producing negative developmental effects. Case reports in man have suggested that marijuana may be teratogenic, but maternal use of multiple drugs in some of those reports precluded determination of a causal effect specific for Cannabis (5-7). Furthermore, epidemiologic studies have not suggested a teratogenic effect (8, 9) . Animal investigations of marijuana teratogenicity have been inconclusive, with the majority of evidence indicating teratogenicity occurs only if exposure is very early in pregnancy and the administered dose is very high (8) .
On the other hand, most of the animal studies have shown that intrauterine exposure to marijuana extract or THC is fetotoxic, resulting in low birth weight or IUGR (8) . In man, one epidemiologic project has been able to identify marijuana smoking as a cause of IUGR, independent of other drugs (9) .
Normal fetal growth requires a milieu in which adequate nutritional components are available for full expression of genetically determined cellular differentiation and proliferation. The fetus is dependent on an external supply of nutrients to develop properly. Throughout most of pregnancy, the placenta is the major source of nutrients via maternal-to-fetal transfer. One category of nutrients, amino acids, is vital to normal fetal growth. Essential neutral amino acids are transferred across the placenta by a stereo-specific, energy-dependent, membrane-associated, saturable active transport process (10) . Impairment of this or any other vital placental cellular function by maternal use of xenobiotic may contribute to IUGR, as postulated for ethanol (1 1, 12) . Therefore, we have examined the possibility that THC is placento-toxic. The effect of THC on in vitro uptake of neutral amino acids by term human placental slices is utilized as an index of this potential placento-toxicity. EBSS (pH = 7.4) with glucose (1 glliter) and phenol red, was purchased from MA Bioproducts (Walkersville, MD). I4C-AIB, I4C-Val, and I4C-inulin were obtained from New England Nuclear Corp. (Boston, MA). THC was provided by the National Institute on Drug Abuse in glass ampules containing 10 mg THC in 1 ml 95% ethanol.
Term human placentae were obtained from healthy women at the time of vaginal delivery. All women denied the use of ethanol, tobacco, and marijuana. Each placenta was placed on ice and immediately transported to the laboratory for preparation of villous slices according to a modification of methods previously described (13, 14) . Slices of villous tissue (20-50 mg pressed weight) were washed once in ice-cold saline and twice in EBSS. They were then preincubated at 37" C for 30 min in a sealed flask containing EBSS (2 ml/slice), which had been aerated with 95% 02/5% C02. The tissue was transferred to another flask of fresh, aerated EBSS for 15 min, representing a second preincubation. The medium from this second preincubation contains modest amounts of endogenous placental protein. The THC added to the "final" incubation medium requires protein to hold it in suspension. Thus, some of the second preincubation medium was used to adjust the protein concentration of the final incubation medium to 2 mg/dl prior to addition of the THC.
THC in 95% ethanol was added to this final medium to achieve desired concentrations (corresponding amounts of 95% ethanol were added to control medium). For dose-response and timecourse experiments, the final medium was used for measurement of amino acid uptake in the presence or absence (control) of THC. For reversibility and kinetics experiments, only AIB uptake was determined. The final medium was divided into two batches. The first batch was used for 90 rnin of drug (or control) exposure, without any AIB present. This was followed by 60 min (reversibility) or 20 min (kinetics) of AIB uptake with or without THC.
Uptake of amino acid was measured by the method of Smith el al. (13) as modified by Fisher el al. (14) . Each sealed 25-ml incubation flask contained 5 ml of aerated final medium and two placental slices. The concentration of amino acid in the final medium was 125 pM for AIB or 50 pM for Val. Wet weight was determined after blotting and then pressing with a 2-kg weight for 20 rnin at 4" C. After correcting for extracellular water using the inulin space, uptake was expressed as the R of radioactivity in the intracellular water to radioactivity in the medium. For the kinetics experiments, the final concentrations of AIB in the medium ranged between 1.0 pM and 50 mM. The Kd and Y were calculated according to the method of Akedo and Christensen (1 5), as described by Smith el al. (1 3) . The other parameters were calculated from a Woolf-Augustinsson-Hofstee plot (16) , with the negative slope representing the Km and the y-intercept the Vmax.
Light microscopy and transmission EM on fresh tissue and tissue exposed for 90 min to drug-containing or control medium were performed after fixation in either 10% formalin (light) or 2% glutaraldehyde in cacodylate buffer (EM). Protein was determined by the method of Lowry el al. (17) .
Grouped data were analyzed by the t test for paired data or by ANOVA. Differences between means were considered significant at p < 0.05. These comparisions were performed on the Minitab Statistical Computing System (University Park, PA). Similarly, Minitab was utilized to compute correlation coefficients and linear regressions.
RESULTS
Light microscopy and EM did not show any difference in villous tissue between control and 50 pM THC exposure. Under EM, the nuclei of the syncytiotrophoblast cells appeared less dense than those of the cytotrophoblasts after 90 min of incubation, but this was unrelated to drug treatment.
Using %-THC as a tracer, 25-30% of the THC in the medium was found to adhere to the glassware. This proportion of loss to glassware adherence was constant throughout the range of nominal THC concentrations in the medium. Conversely, THC levels in the tissue were 15-to 20-fold elevated relative to the nominal medium concentrations. With 2 pM THC in the medium (2 nmol THC/ml medium), the tissue THC concentration was 40.5 + 3.5 nmol/g pressed weight (n = 6; with correction for extracellular space using I4C-inulin); at 5 pM THC in the medium it was 75.8 k 7.9 nmol/g; at 50 pM THC in the medium it was 847.1 + 78.1 nmol/g. Following 60 rnin of "washout" with THCfree medium, the tissue concentration was reduced by only 18.1 k 2.4%.
Human placental slice uptake of AIB, in the presence of THC, was impaired in a dose dependent fashion, from 1.0 to 100 pM THC (Fig. 1) . Compared to control uptake, significant inhibition occurred initially with 20 pM ( p < 0.05, ANOVA). With 50 pM, uptake was reduced by nearly 30% ( p < 0.01, ANOVA). The effect of 50 pM THC on valine uptake was tested in six placentae and followed the same pattern: control = 7.73 + 0.66; 1 pM THC = 7.54 rt 0.68; 5 pM THC = 7.45 + 0.5 1; 10 pM THC = 7.06 + 0.60; 50 pM THC = 5.83 k 0.64. The 50 pM treatment was significantly lower than control ( p < 0.05; ANOVA).
To see how quickly THC might alter AIB uptake, and whether or not the effect might be continuous and additive over the short term, slices were exposed to 50 pM THC for 30-120 rnin (Fig.  2) . Uptake was linear for both control and THC, but the slope was reduced for THC exposed tissue. Inhibition of AIB uptake was seen at 30 min and continued throughout (p < 0.05, paired t test). Thus, uptake reduction was relatively rapid and continuous. In five placentae, potential reversibility was tested by exposing tissue to 50 pM THC for 90 min, followed by 60-min AIB uptake with (continuous exposure) or without (potential reversal) 50 pM THC. Control tissue was treated identically, without any THC exposure at any time. There was slight reversal of the 50 pM THC effect on AIB uptake. The continuous exposure tissue had uptake which was 72.0 + 6.6% of matched controls ( p < The results of the kinetics experiments are illustrated by the plot of Y versus Y/C, for one representative placenta (Fig. 3) .
The plot demonstrates noncompetitive inhibition by 50 pM THC, in that the Km (negative slope) is essentially unaltered, while there is a 50% fall in the Vmax (y intercept). When the data from five placentae are compared (Table l) , there is a significant decrease in Vmax ( p < 0.01, paired t test), but no significant change in Km. In addition, THC exposure caused a slight increase in Kd but the difference was not significant (paired t test).
DISCUSSION
Using exclusively human placental tissue, our results indicate that THC has the potential to impair maternal-to-fetal transfer of essential amino acids. The primary substrate for the studies was AIB, an actively transported, nonmetabolized amino acid which is frequently used as a model for sodium-dependent neutral amino acid uptake by the human placenta. For comparison, limited experiments were also performed with Val, an actively transported, mostly sodium-independent amino acid. Under our in vitro conditions, term human placenta slice uptake of AIB is linear for several hours (13, 14) . Yet, within 30 min, THC began to impair AIB uptake in a dose-dependent fashion. Similar results were obtained with Val. The effect of THC on both amino acid systems suggests a generalized impairment of cellular function, with amino acid uptake serving as an index of cytotoxicity. Fig. 3 . Kinetics of AIB uptake with 50 pM THC (0) versus control (a). In these data from a single placenta, velocity of uptake (Y) is plotted against velocity divided by concentration of AIB in the medium (YIC,). With 50 pM THC there is a fall in Vmax (y intercept) and essentially no change in Km (negative slope). These findings suggest noncompetitive inhibition of AlB uptake by 50 pM THC (see also Inhibition of either AIB or Val uptake during our short-term incubations required relatively high concentrations of THC (>lo pM) in the medium. Although adherence to glassware reduced the nominal concentration, it was still in excess of that found in plasma. For example, inhalation of THC from one marijuana cigarette may result in a peak blood level of approximately 0.3 pM (18) . On the other hand, our inhibitory concentrations are similar to those used by other investigators to demonstrate the in vitro effects of THC on cellular metabolism and transport of macromolecular precursors (4, (19) (20) (21) (22) . Specifically, 1 0-4 to 1 Oe5 M THC inhibits uptake of AIB (20) and leucine (22) by cultured lymphocytes. Furthermore, THC and its metabolites are lipophilic and accumulate in the body, especially within fatty tissue and cell membranes (23) (24) (25) (26) . The placenta in particular, is a tissue that tends to accumulate THC in vivo (27) . This was paralleled by the results of our in vitro observations where tissue concentrations were in excess of those in the medium.
A similar interpretative problem exists for the placento-toxicity of ethanol: very high concentrations of ethanol are required to acutely alter AIB uptake by human placental slices (14) ; yet the primate placenta (the experimental model closest to the human) and rodent placenta show diminished amino acid uptake when the animals are chronically exposed to ethanol (27) (28) (29) . As to the ethanol in which the THC was supplied, control tissue was similarly treated, and the highest ethanol concentration achieved, 240 mg/dl for 100 pM THC, is well below that which acutely alters AIB uptake (> 1000 mg/dl) (1 4).
Unlike ethanol, the short-term effects of THC exposure on human placental AIB uptake are only modestly reversed by simply removing the drug. This may be related to cellular accumulation of THC since high tissue levels remain despite 60 min of washout. In vitro, the extremely low aqueous solubility of THC would cause it to remain bound to membrane lipids and possibly intracellular protein (26, 31, 32) . Furthermore, the relatively low protein concentration in the medium would also favor tissue retention since in vitro toxicity of THC has been shown to correlate inversely with the protein concentration of the medium (22) .
Accumulation of THC within the tissue and subsequent interference with AIB uptake is supported by the kinetics studies. Specifically, there was evidence of noncompetitive inhibition, as indicated by the fall in Vmax without any change in Km. No specific mechanism can be inferred from our data, but other studies have suggested that THC alters cell function by membrane changes (20,3 1), diminished glycolysis (33) , and decreased Na,K-ATPase activity (34) (35) (36) . All three could be applicable to our findings, in that placental uptake of AIB is dependent on putative membrane-bound carriers, an aerobic source of energy and Na,K-ATPase (10). The effect of THC on Val, which is not dependent on Na,K-ATPase, would argue for more nonspecific metabolic or membrane changes. The latter is an important general mechanism for THC cytotoxicity (37) . Although there was a small increase in Kd with THC exposure, implying an alteration in membrane permeability, the difference was not significant. Back diffusion or cellular leakage of AIB is not likely to have been responsible for the net decrease in AIB uptake associated with THC exposure (20) .
The results of our in vitro studies indicate that THC has the potential to be placento-toxic in the human. Using actively transported amino acids as an index, it is suggested that THC could accumulate in the placenta and interfere with transport of essential amino acids or other macromolecular precursors. Hence, THC placento-toxicity could deprive the fetus of certain nutrients required for normal intrauterine growth. However, because our in vitro studies required very high THC concentrations to demonstrate toxicity, animal investigations are underway to evaluate the placento-toxicity of THC at blood concentrations similar to those found in man. Furthermore, the in vitro findings with the placenta do not preclude the possibility of direct THC feto-toxicity. Since THC crosses the placenta, both placento-and feto-toxicity could play a role in the IUGR seen with human use of THC during pregnancy.
